Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Corcept Therapeutics
M.D. Anderson Cancer Center
Pfizer
Pathos AI, Inc.
Stemline Therapeutics, Inc.
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Eli Lilly and Company
K36 Therapeutics, Inc.